UCB BioSciences GmbH
π©πͺGermany
Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-09-17
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 317
- Registration Number
- NCT02552212
- Locations
- πΊπΈ
As0006 138, Plantation, Florida, United States
πΊπΈAs0006 144, Philadelphia, Pennsylvania, United States
πΊπΈAs0006 148, Atlanta, Georgia, United States
Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 736
- Registration Number
- NCT02505542
- Locations
- π¨πΏ
As0005 1309, Bruntal, Czechia
πΊπΈAs0005 2317, Sun City, Arizona, United States
πΊπΈAs0005 2307, Palm Desert, California, United States
Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors
Completed
- Conditions
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2020-06-01
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 93
- Registration Number
- NCT02276053
- Locations
- π«π·
337, Lille, France
π«π·334, Lyon Cedex, France
π©πͺ491, Bonn, Germany
A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-09-03
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 57
- Registration Number
- NCT02230904
- Locations
- π©πͺ
103, Stuttgart, Germany
π©πͺ102, Karlstadt, Germany
π©πͺ109, Erbach, Germany
Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2014-10-20
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 26
- Registration Number
- NCT01854216
- Locations
- π©πͺ
1, Neuss, Germany
Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects
- First Posted Date
- 2013-02-22
- Last Posted Date
- 2014-10-20
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT01796938
- Locations
- π©πͺ
1, Cologne, Germany
π©πͺ2, Rendsburg, Germany
Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy
- First Posted Date
- 2013-02-01
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 122
- Registration Number
- NCT01782222
- Locations
- πΈπ°
3801, Banska Bystrica, Slovakia
π΅π±3506, Gdynia, Poland
π¦πΉ3003, Linz, Austria
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2014-10-20
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 50
- Registration Number
- NCT01761526
- Locations
- π©πͺ
01, Neuss, Germany
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2015-05-01
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 68
- Registration Number
- NCT01744496
- Locations
- πΊπΈ
2101, Roanoke, Virginia, United States
πΊπΈ2104, Milwaukee, Wisconsin, United States
π΅π±1607, Gdansk, Poland
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
- First Posted Date
- 2012-11-08
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 90
- Registration Number
- NCT01723904
- Locations
- π¦πΊ
402, Chatswood, New South Wales, Australia
π°π·112, Busan, Korea, Republic of
π°π·101, Seoul, Korea, Republic of
Β© Copyright 2024. All Rights Reserved by MedPath